Clifford Chance
Clifford Chance advises Gilde Healthcare on the financing of its acquisition of Sanquin Reagents
2 November 2022
Clifford Chance advises Gilde Healthcare on the financing of its acquisition of Sanquin Reagents
International law firm Clifford Chance has advised specialised healthcare investor Gilde Healthcare on the financing provided by LGT Capital Partners of the acquisition by Gilde Healthcare of Sanquin Reagents. Read more about it here.
The Clifford Chance team was led by Boudewijn Vermeer and further consisted of Daniela Chilkevitsh, Inge de Bruin and Robin Houtveen.
